Chromosomal translocations involving the neurotrophin receptor tyrosine kinase genes NTRK1, NTRK2 or NTRK3 lead to TRK gene fusions, resulting in the overexpression of the proteins, their constitutive activation and subsequent tumour growth. The gene discussed is NTRK1; the disease is neoplasm.